Provided by Tiger Trade Technology Pte. Ltd.

Alumis Inc.

7.16
+0.19002.73%
Post-market: 6.91-0.2500-3.49%19:30 EDT
Volume:1.37M
Turnover:9.75M
Market Cap:923.64M
PE:-1.88
High:7.29
Open:7.04
Low:6.90
Close:6.97
52wk High:31.35
52wk Low:4.28
Shares:129.00M
Float Shares:97.15M
Volume Ratio:0.52
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8005
EPS(LYR):-2.8616
ROE:-93.65%
ROA:-45.34%
PB:2.04
PE(LYR):-2.50

Loading ...

Alumis - Topline Data from Lumus Phase 2B Trial in Lupus Expected in Q3 2026

THOMSON REUTERS
·
Aug 11

Alumis - to Submit Nda to FDA for Envudeucitinib in Q4 2026

THOMSON REUTERS
·
Aug 11

Alumis - 75% of Patients Achieve Pasi 90, 54% Achieve Pasi 100 After 48 Weeks

THOMSON REUTERS
·
Aug 11

Alumis Says Envudeucitinib Hits 54% PASI 100 at 48 Weeks in Onward3 Plaque Psoriasis Extension Study

Reuters
·
Aug 11

Envudeucitinib Long-term Data Positioned to Set a New Standard for Plaque Psoriasis Treatment, Delivering Highest Reported PASI 100 Skin Clearance Among Oral Therapies

GlobeNewswire
·
Aug 11

Alumis: Competitive Pressures and Dosing Drawbacks Support Hold Rating and Unchanged $25 Price Target

TIPRANKS
·
Aug 03

Alumis Price Target Maintained with a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 03

Alia Mentis Files Share Capital Increase After Greenshoe Exercise

TIPRANKS
·
Jul 28

Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS) and AbCellera Biologics (ABCL)

TIPRANKS
·
Jul 16

Alumis Inc. (ALMS) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Jul 10

Top Alumis Insider Makes Notable Move With Significant Stock Sale

TIPRANKS
·
Jul 09

Alumis Chief Legal Officer Sanam Pangali Disposes of Common Shares Worth $140,000

Reuters
·
Jul 09

Alumis Shareholders Reelect Directors and Ratify Auditor

TIPRANKS
·
Jul 03

Alumis Holds Annual Shareholder Meeting

Reuters
·
Jul 03

Alumis (ALMS) Joins Growth Indices, Is The Stock Overvalued?

Simply Wall St.
·
Jul 03

Analysts Conflicted on These Healthcare Names: Alumis Inc. (ALMS), Glaukos (GKOS) and Regeneron (REGN)

TIPRANKS
·
Jul 01

Alumis Highlights TYK2 Strategy in Updated Investor Presentation

TIPRANKS
·
Jun 29

Alumis management to meet with Cantor

TIPRANKS
·
Jun 27

Maplight Therapeutics Names Martin Babler, Troy Cox to Board of Directors

Reuters
·
Jun 24

Alumis rises 10.3%

TIPRANKS
·
Jun 13